Yohei Doi

59PUBLICATIONS
138CO-AUTHORS
Medical infection agents (incl. prions)Major global burdens of diseaseEnvironmental epidemiologySocial determinants of healthMedical bacteriology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Aug 17, 2026
Phenotypic screening of hypervirulent Klebsiella pneumoniae using tellurite resistance and carbohydrate fermentation testing.

|Apr 27, 2026
Difficult-to-treat resistance (DTR), treatment, and outcomes of carbapenem-resistant Enterobacterales infections in the setting of IMP-type carbapenemase predominance in Japan.

|Apr 08, 2026
A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

Akito Kawai, Christi L McElheny, Ryan K Shields

|Apr 06, 2026
Case Commentary: When one target is not enough-PBP3 insertions and target redundancy in Escherichia coli.

Madison E Stellfox, Yohei Doi

|Mar 08, 2026
Escherichia coli ST131 Drives Carbapenem Use for E. coli Bloodstream Infections.

Natalie A Mackow, Wanying Shao, Lizhao Ge

|Feb 11, 2026
Real-world effectiveness of early remdesivir in reducing mortality among vulnerable patients hospitalized for COVID-19: Evidence for clinical pharmacists and inpatient care providers.

Paul Loubet, Aastha Chandak, Susan Spivey

Pageof 10

Frequent Collaborators

14 joint publications

David van Duin

12 joint publications

Masahiro Suzuki

11 joint publications

Ryan K Shields

7 joint publications

Daria Van Tyne